Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

AI-powered solution for personalized treatment of heart failure patients

Heart failure is the leading cause of hospitalisation in those over 65 and research predicts that the condition will increase in global prevalence by almost 50% by 2030.

23 Jun 2023

Prior exposure to air pollutants and black carbon load predicts outcomes in hospitalized COVID-19 patients

Researchers investigated whether black carbon particles in the blood increased COVID-19 severity.

23 Jun 2023

Omega-3 fatty acids linked to lower atrial fibrillation risk in U.S. veterans

Researchers determine whether marine omega-3 fatty acid consumption increases atrial fibrillation risk among United States military veterans.

22 Jun 2023

Plant based compound peruvoside may be able to prevent up to 12 medically important viruses

Peruvoside, a plant-based compound that is commonly used to treat heart failure, has been discovered to be able to prevent up to 12 medically important viruses, all originating from different virus families.

22 Jun 2023

The effect of SGLT2 inhibitors in patients with heart failure and type 2 diabetes

Researchers assessed the impact of SGLT2 inhibitors on type 2 diabetes and heart failure patients in real-world clinical settings.

21 Jun 2023

Uncovering the hidden genetic connections behind COVID-19 and comorbidities

Researchers performed a protein diffusion network analysis using tissue-specific GRNs to identify predispositions to COVID-19.

21 Jun 2023

Vegetarian diet linked to increased risk of varicose veins in men

Varicose veins (VVs) pose a significant medical burden, particularly among women. This study investigates the association between vegetarian and non-vegetarian diets and the risk of VVs in both genders.

20 Jun 2023

New measurement tool helps analyze quality of life after childhood cancer

A new measurement tool helps analyze the survival rate of children with cancer, but also the quality of survival.

20 Jun 2023

What are the potential long-term effects on healthcare and the economy due to decreased STEMI treatment during the COVID-19 pandemic?

Researchers predicted long-term health consequences and expenses associated with ST-elevation myocardial infarction (STEMI) treatment during the first COVID-19 lockdown.

20 Jun 2023

Comparing the cost-effectiveness of SGLT2i versus mineralocorticoid antagonists

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are approved for heart failure with reduced ejection fraction (HFrEF).

19 Jun 2023

Radioactive iodine or surgery linked to decreased mortality risk in patients with hyperthyroidism

Hyperthyroidism treatment like radioactive iodine or surgery was associated with a decreased risk for death, according to research being presented Saturday at ENDO 2023, the Endocrine Society's annual meeting in Chicago.

18 Jun 2023

Insilico announces new multimodal transformer-based aging clock for processing diverse data sets

Clinical stage generative artificial intelligence (AI)-driven drug discovery company Insilico Medicine ("Insilico") has announced a new multimodal transformer-based aging clock that is capable of processing diverse data sets and providing insights into biomarkers for aging, mapping them to genes relevant to both aging and disease, and discovering new therapeutic targets designed to slow or reverse both aging and aging-related diseases.

15 Jun 2023

Simple juice concentrate from the Japanese plum may reduce cardiovascular disease risk

More than 122 million Americans – about half of the U.S. population ages 20 and older – have high blood pressure, referred to medically as hypertension.

13 Jun 2023

International researchers put forward landmark proposal to diagnose, treat heart disease with neuromodulation technologies

Professor Kalyanam Shivkumar of David Geffen School of Medicine at UCLA in collaboration with Professor David Paterson, of Oxford University has been awarded a prestigious Leducq International Network of Excellence Program Award of $8 million to set up a major new transatlantic network linking world leading researchers from the United States and Europe to develop bioelectronics and therapies that target the nervous system to treat heart diseases.

13 Jun 2023

How innovative technology aids in the fight against diabetes epidemic

Dr Chris Tackaberry, CEO of healthtech AI pioneers Clinithink, highlights the crisis facing the NHS and the importance of Diabetes Week from June 12-18. Every week, diabetes leads to around 180 amputations, 590 heart attacks and 2,300 cases of heart failure. The financial impact of this on the NHS is eye watering.

10 Jun 2023

New scientific statement details treatment strategies for pediatric cardiomyopathy

Treating children with cardiomyopathy should be personalized based on the root cause, symptoms and progression of the condition in each child , according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

8 Jun 2023

ATTR amyloidosis cardiomyopathy can be reversed, study reports

Three men who had heart failure caused by the build-up of sticky, toxic proteins are now free of symptoms after their condition spontaneously reversed in an unprecedented case described by a team at UCL (University College London) and the Royal Free Hospital.

7 Jun 2023

Heart Failure News and Research

Further Reading

AI-powered solution for personalized treatment of heart failure patients

Prior exposure to air pollutants and black carbon load predicts outcomes in hospitalized COVID-19 patients

Omega-3 fatty acids linked to lower atrial fibrillation risk in U.S. veterans

Plant based compound peruvoside may be able to prevent up to 12 medically important viruses

The effect of SGLT2 inhibitors in patients with heart failure and type 2 diabetes

Uncovering the hidden genetic connections behind COVID-19 and comorbidities

Vegetarian diet linked to increased risk of varicose veins in men

New measurement tool helps analyze quality of life after childhood cancer

What are the potential long-term effects on healthcare and the economy due to decreased STEMI treatment during the COVID-19 pandemic?

Comparing the cost-effectiveness of SGLT2i versus mineralocorticoid antagonists

Radioactive iodine or surgery linked to decreased mortality risk in patients with hyperthyroidism

Insilico announces new multimodal transformer-based aging clock for processing diverse data sets

Simple juice concentrate from the Japanese plum may reduce cardiovascular disease risk

International researchers put forward landmark proposal to diagnose, treat heart disease with neuromodulation technologies

How innovative technology aids in the fight against diabetes epidemic

New scientific statement details treatment strategies for pediatric cardiomyopathy

ATTR amyloidosis cardiomyopathy can be reversed, study reports

Heart attack during the first COVID-19 lockdown reduced two years of patients’ lives

Most adults with diabetes do not receive prompt outpatient care after heart failure hospitalization

Study finds an increased disease burden in middle-aged and older autistic adults

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News